{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:57:41Z","timestamp":1792648661669,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cld.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T21:16:13Z","timestamp":1656105373000},"page":"403-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatitis B and C in Children"],"prefix":"10.1016","volume":"26","author":[{"given":"A. Bailey","family":"Sperry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cld.2022.03.005_bib1","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3390\/microorganisms9081787","article-title":"Hepatitis B virus DNA integration, chronic infections and hepatocellular carcinoma","volume":"9","author":"Bousali","year":"2021","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.cld.2022.03.005_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.03.005_bib3","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2022.03.005_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","article-title":"Epidemiology of hepatitis B virus infection and impact of vaccination on disease","volume":"20","author":"Nelson","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2022.03.005_bib5","series-title":"Global health sector Strategy on viral hepatitis 2016-2021","year":"2016"},{"issue":"5","key":"10.1016\/j.cld.2022.03.005_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/v12050515","article-title":"The lived experience of chronic hepatitis B: a broader view of its impacts and why we need a cure","volume":"12","author":"Tu","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.cld.2022.03.005_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/MPG.0b013e318197196e","article-title":"Management of chronic hepatitis B in children","volume":"48","author":"Shah","year":"2009","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.cld.2022.03.005_bib8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S2468-1253(19)30042-1","article-title":"Hepatitis B virus infection in children and adolescents","volume":"4","author":"Indolfi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.03.005_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpeds.2021.05.035","article-title":"Chronic hepatitis is common and often untreated among children with hepatitis B infection in the United States and Canada","volume":"237","author":"Ling","year":"2021","journal-title":"J\u00a0Pediatr"},{"issue":"3\u20134","key":"10.1016\/j.cld.2022.03.005_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000360947","article-title":"Genotypes and genetic variability of hepatitis B virus","volume":"57","author":"Kramvis","year":"2014","journal-title":"Intervirology"},{"issue":"1Suppl","key":"10.1016\/j.cld.2022.03.005_bib11","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jhep.2016.01.027","article-title":"Overview of hepatitis B viral replication and genetic variability","volume":"64","author":"Tong","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.03.005_bib12","first-page":"S119","article-title":"Chapter 6.1. Pediatric chronic hepatitis B and C: 30 Years of ESPGHAN clinical research and recommendations","volume":"66Suppl1","author":"Sokal","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cgh.2014.06.028","article-title":"Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype","volume":"13","author":"Ghany","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.03.005_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bpg.2017.04.010","article-title":"Natural history of acute and chronic hepatitis B: the role of HBV genotypes and mutants","volume":"31","author":"Lin","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.gastro.2015.09.043","article-title":"Combination of tenofovir disoproxil fumarate and peginterferon\u03b1-2a increases loss of hepatitis B surface antigen in patients with chronic hepatitis B","volume":"150","author":"Marcellin","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/vaccines8020156","article-title":"Hepatitis B seroprevalence in the pediatric and adolescent population of florence (Italy): An update 27 years after the Implementation of Universal Vaccination","volume":"8","author":"Zanella","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.cld.2022.03.005_bib18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jhep.2013.05.016","article-title":"Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines","volume":"59","author":"Sokal","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1742-1241.2003.tb10435.x","article-title":"Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers","volume":"57","author":"Wang","year":"2003","journal-title":"Int J Clin Pract"},{"issue":"24","key":"10.1016\/j.cld.2022.03.005_bib20","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis B transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/hep.27837","article-title":"Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus","volume":"62","author":"Chen","year":"2015","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2022.03.005_bib22","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/cid\/ciw159","article-title":"In utero tenofovir exposure is not associated with fetal long bone growth","volume":"62","author":"Jao","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.cld.2022.03.005_bib23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/AAC.00514-10","article-title":"Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire","volume":"55","author":"Benaboud","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/QAI.0b013e3182a921eb","article-title":"Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life","volume":"65","author":"Mirochnick","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cld.2022.03.005_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpeds.2021.07.017","article-title":"Hepatitis B in children-the pursuit of a hepatitis free future generation","volume":"237","author":"Coffin","year":"2021","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.cld.2022.03.005_bib26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/hep.21077","article-title":"Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study","volume":"43","author":"Bortolotti","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2022.03.005_bib27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jhep.2012.03.036","article-title":"Chronic hepatitis B in children and adolescents","volume":"57","author":"Paganelli","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.26385","article-title":"Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles","volume":"58","author":"Lee","year":"2013","journal-title":"Hepatology"},{"issue":"1Suppl","key":"10.1016\/j.cld.2022.03.005_bib29","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"28","key":"10.1016\/j.cld.2022.03.005_bib30","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.3748\/wjg.v27.i28.4603","article-title":"Viral hepatitis: Milestones, unresolved issues, and future goals","volume":"27","author":"Torre","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2022.03.005_bib31","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/jp.2014.167","article-title":"Hepatitis B and C in pregnancy: a review and recommendations for care","volume":"34","author":"Dunkelberg","year":"2014","journal-title":"J\u00a0Perinatol"},{"issue":"20","key":"10.1016\/j.cld.2022.03.005_bib32","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3748\/wjg.v27.i20.2474","article-title":"Breakthroughs and challenges in the management of pediatric viral hepatitis","volume":"27","author":"Nicastro","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jpeds.2005.09.020","article-title":"Combined lamivudine\/interferon-alpha treatment in \"immunotolerant\" children perinatally infected with hepatitis B: a pilot study","volume":"148","author":"D'Antiga","year":"2006","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.cld.2022.03.005_bib34","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/hep.30312","article-title":"Combination of Entecavir\/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection","volume":"69","author":"Rosenthal","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/SGA.0000000000000223","article-title":"The social stigma experience in patients with hepatitis B infection: a Qualitative study","volume":"40","author":"Valizadeh","year":"2017","journal-title":"Gastroenterol Nurs"},{"issue":"44","key":"10.1016\/j.cld.2022.03.005_bib36","doi-asserted-by":"crossref","first-page":"7880","DOI":"10.3748\/wjg.v19.i44.7880","article-title":"Burden of pediatric hepatitis C","volume":"19","author":"El-Shabrawi","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2022.03.005_bib37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S2468-1253(19)30385-1","article-title":"Global prevalence of hepatitis C virus in children in 2018: a modelling study","volume":"5","author":"Schmelzer","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"26","key":"10.1016\/j.cld.2022.03.005_bib38","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.3748\/wjg.v27.i26.4018","article-title":"Viral hepatitis update: progress and perspectives","volume":"27","author":"Pisano","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2022.03.005_bib39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/JCM.02831-14","article-title":"Hepatitis C virus genotype 7, a new genotype originating from central Africa","volume":"53","author":"Murphy","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2022.03.005_bib41","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","article-title":"Identification of a Novel hepatitis C virus genotype from Punjab, India: Expanding classification of hepatitis C virus into 8 genotypes","volume":"218","author":"Borgia","year":"2018","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.cld.2022.03.005_bib42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1537-2995.2007.01162.x","article-title":"The epidemiology of transfusion-associated hepatitis C in a children\u2019s hospital","volume":"47","author":"Luban","year":"2007","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.cld.2022.03.005_bib43","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1016\/j.ijid.2010.03.019","article-title":"Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis","volume":"14","author":"Jafari","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.cld.2022.03.005_bib44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.cld.2022.03.005_bib45","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/hep.28032","article-title":"HCV vertical transmission in pregnancy: new horizons in the era of DAAs","volume":"62","author":"Kanninen","year":"2015","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.cld.2022.03.005_bib46","first-page":"537","article-title":"Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.cld.2022.03.005_bib47","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.cld.2022.03.005_bib48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/M16-2350","article-title":"Hepatitis C virus infection among Reproductive-aged women and children in the United States, 2006 to 2014","volume":"166","author":"Ly","year":"2017","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.cld.2022.03.005_bib49","doi-asserted-by":"crossref","first-page":"470","DOI":"10.15585\/mmwr.mm6618a3","article-title":"Hepatitis C virus infection among women giving birth-Tennessee and United States, 2009-2014","volume":"66","author":"Patrick","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.cld.2022.03.005_bib50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MPG.0000000000002814","article-title":"Hepatitis C in 2020: a North American society for pediatric Gastroenterology, Hepatology, and Nutrition position paper","volume":"71","author":"Leung","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib51","doi-asserted-by":"crossref","first-page":"F156","DOI":"10.1136\/adc.2004.059436","article-title":"When does mother to child transmission of hepatitis C virus occur?","volume":"90","author":"Mok","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.cld.2022.03.005_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejogrb.2018.03.034","article-title":"Mother-to-child transmission of hepatitis C virus","volume":"224","author":"Pott","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"10.1016\/j.cld.2022.03.005_bib53","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/512815","article-title":"Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis","volume":"44","author":"Polis","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.cld.2022.03.005_bib54","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1086\/516102","article-title":"Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1","volume":"25","author":"Tovo","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/jpids\/pis091","article-title":"Mother-to-Child transmission of hepatitis C virus (HCV) among HIV\/HCV-coinfected women","volume":"2","author":"Checa Cabot","year":"2013","journal-title":"J\u00a0Pediatr Infect Dis Soc"},{"key":"10.1016\/j.cld.2022.03.005_bib56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcv.2015.04.002","article-title":"Low mother-to-child-transmission rate of Hepatitis C virus in cART treated HIV-1 infected mothers","volume":"68","author":"Snijdewind","year":"2015","journal-title":"J\u00a0Clin Virol"},{"issue":"5","key":"10.1016\/j.cld.2022.03.005_bib57","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.039","article-title":"Hepatitis C in pregnancy: screening, treatment, and management","volume":"217","author":"Hughes","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.cld.2022.03.005_bib58","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.clinthera.2018.07.010","article-title":"Unique challenges of hepatitis C in infants, children, and adolescents","volume":"40","author":"Espinosa","year":"2018","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.cld.2022.03.005_bib59","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/hep.24298","article-title":"Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children","volume":"53","author":"Ruiz-Extremera","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2022.03.005_bib60","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/gutjnl-2013-306287","article-title":"Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection","volume":"64","author":"Fitzmaurice","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virol.2009.05.007","article-title":"Genetic factors in mother-to-child transmission of HCV infection","volume":"390","author":"Bevilacqua","year":"2009","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib62","doi-asserted-by":"crossref","first-page":"e0172527","DOI":"10.1371\/journal.pone.0172527","article-title":"Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children","volume":"12","author":"Ruiz-Extremera","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cld.2022.03.005_bib63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jmv.10405","article-title":"Clinical features and progression of perinatally acquired hepatitis C virus infection","volume":"70","author":"Resti","year":"2003","journal-title":"J\u00a0Med Virol"},{"issue":"5","key":"10.1016\/j.cld.2022.03.005_bib64","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/MPG.0000000000000275","article-title":"Interleukin 28B rs12979860 single-nucleotide polymorphism predicts spontaneous clearance of hepatitis C virus in children","volume":"58","author":"Indolfi","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"11","key":"10.1016\/j.cld.2022.03.005_bib65","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/nm.3351","article-title":"Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses","volume":"19","author":"Honegger","year":"2013","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.cld.2022.03.005_bib66","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/MPG.0b013e318258328d","article-title":"NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents","volume":"54","author":"Mack","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"17","key":"10.1016\/j.cld.2022.03.005_bib67","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged \u226430 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012","volume":"64","author":"Zibbell","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cld.2022.03.005_bib68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jpeds.2017.09.016","article-title":"Increasing prevalence of hepatitis C among hospitalized children is associated with an increase in substance abuse","volume":"192","author":"Barritt","year":"2018","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00003727-200207000-00005","article-title":"Hepatitis B and C infections among homeless adolescents","volume":"25","author":"Beech","year":"2002","journal-title":"Fam Community Health"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib70","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1542\/peds.111.1.153","article-title":"Prevalence of hepatitis C virus infection and risk factors in an incarcerated juvenile population","volume":"111","author":"Murray","year":"2003","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.cld.2022.03.005_bib71","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib72","doi-asserted-by":"crossref","first-page":"22146","DOI":"10.7448\/IAS.20.1.22146","article-title":"Elimination of HCV as a public health concern among people who inject drugs by 2030 - what will it take to get there?","volume":"20","author":"Grebely","year":"2017","journal-title":"J\u00a0Int AIDS Soc"},{"issue":"Suppl2","key":"10.1016\/j.cld.2022.03.005_bib73","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1093\/cid\/cit296","article-title":"Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral teatment, needle and syringe programs, and opiate substitution therapy","volume":"57","author":"Martin","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.cld.2022.03.005_bib74","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/jvh.13111","article-title":"Treatment and monitoring of children with chronic hepatitis C in the Pre-DAA era: a European survey of 38 paediatric specialists","volume":"26","author":"Indolfi","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2022.03.005_bib75","series-title":"Red Book: 2021-2024 Report of the Committee on Infectious Diseases","year":"2021"},{"issue":"11","key":"10.1016\/j.cld.2022.03.005_bib76","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.cgh.2018.04.050","article-title":"A\u00a0Learning collaborative approach increases specificity of diagnosis of acute liver failure in pediatric patients","volume":"16","author":"Narkewicz","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib77","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep4.1028","article-title":"Hepatitis C virus infection in children and adolescents","volume":"1","author":"Squires","year":"2017","journal-title":"Hepatol Commun"},{"issue":"2Pt1","key":"10.1016\/j.cld.2022.03.005_bib78","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1542\/peds.98.2.211","article-title":"Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin","volume":"98","author":"Jonas","year":"1996","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.cld.2022.03.005_bib79","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpeds.2005.12.051","article-title":"Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group","volume":"148","author":"Squires","year":"2006","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/430601","article-title":"Three broad modalities in the natural history of vertically acquired hepatitis C virus infection","volume":"41","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib81","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/pbc.22438","article-title":"An updated follow-up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy","volume":"55","author":"Cesaro","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.cld.2022.03.005_bib82","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s10620-015-3760-3","article-title":"Concurrent obesity, diabetes, and steatosis increase risk of advanced fibrosis among HCV patients: a systematic review","volume":"60","author":"Dyal","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib83","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00004836-200302000-00016","article-title":"Effect of hepatitis C virus infection and abstinence from alcohol on survival in patients with alcoholic cirrhosis","volume":"36","author":"Serra","year":"2003","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2022.03.005_bib84","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0168-8278(96)80228-5","article-title":"Non-organ specific autoantibodies in children with chronic hepatitis C","volume":"25","author":"Bortolotti","year":"1996","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.03.005_bib85","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2249.1998.00574.x","article-title":"Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection","volume":"112","author":"Gregorio","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2022.03.005_bib86","doi-asserted-by":"crossref","first-page":"785627","DOI":"10.1155\/2012\/785627","article-title":"Autoimmunity and extrahepatic manifestations in treatment-na\u00efve children with chronic hepatitis C virus infection","volume":"2012","author":"Indolfi","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"7","key":"10.1016\/j.cld.2022.03.005_bib87","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1053\/j.gastro.2008.02.082","article-title":"Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease","volume":"134","author":"Bortolotti","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2022.03.005_bib88","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.gtc.2015.07.011","article-title":"Hepatitis C: issues in children","volume":"44","author":"Lee","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"issue":"3","key":"10.1016\/j.cld.2022.03.005_bib89","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1572-0241.2003.07293.x","article-title":"Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?","volume":"98","author":"Guido","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2022.03.005_bib90","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/MPG.0b013e318170af04","article-title":"Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C","volume":"48","author":"Gonz\u00e1lez-Peralta","year":"2009","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.cld.2022.03.005_bib91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1086\/345908","article-title":"Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children","volume":"36","author":"Jara","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib92","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MPG.0b013e3181c61995","article-title":"Chronic hepatitis C virus infection in children","volume":"50","author":"Mohan","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr Feb"},{"issue":"7","key":"10.1016\/j.cld.2022.03.005_bib93","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/lt.20793","article-title":"The natural history of hepatitis C virus in pediatric liver transplant recipients","volume":"12","author":"Barshes","year":"2006","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib94","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1111\/petr.12223","article-title":"Liver transplantation in a child with multifocal hepatocellular carcinoma hepatitis C and management of post-transplant viral recurrence using boceprevir","volume":"18","author":"Malik","year":"2014","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.cld.2022.03.005_bib95","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2018.11.013","article-title":"Epidemiology and natural history of hepatitis C virus infection among children and young people","volume":"70","author":"Modin","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib96","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1053\/j.gastro.2010.10.047","article-title":"The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C","volume":"140","author":"Schwarz","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2022.03.005_bib97","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/1740774507085445","article-title":"Design of the PEDS-C trial: pegylated interferon\u00a0+\/- ribavirin for children with chronic hepatitis C viral infection","volume":"4","author":"Murray","year":"2007","journal-title":"Clin Trials"},{"issue":"4","key":"10.1016\/j.cld.2022.03.005_bib98","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2352-4642(18)30037-3","article-title":"Direct-acting antivirals for children and adolescents with chronic hepatitis C","volume":"2","author":"Indolfi","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"7","key":"10.1016\/j.cld.2022.03.005_bib99","doi-asserted-by":"crossref","first-page":"892","DOI":"10.7150\/ijms.43079","article-title":"Direct-acting antiviral in the treatment of chronic hepatitis C: bonuses and challenges","volume":"17","author":"Zeng","year":"2020","journal-title":"Int J Med Sci"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/hep.28995","article-title":"The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection","volume":"66","author":"Balistreri","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2022.03.005_bib101","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/hep.29278","article-title":"Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection","volume":"66","author":"Wirth","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/hep.30821","article-title":"Sofosbuvir and ribavirin therapy for children aged 3 to <12 Years with hepatitis C virus genotype 2 or 3 infection","volume":"71","author":"Rosenthal","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.03.005_bib103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.31841","article-title":"Pharmacokinetics, safety, and Efficacy of glecaprevir\/pibrentasvir in children with chronic HCV: Part 2 of the DORA study","volume":"74","author":"Jonas","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.03.005_bib104","article-title":"Safety and Efficacy of Sofosbuvir\/Velpatasvir for the Treatment of Chronic Hepatitis C Infection in Children","volume":"13-16","author":"Sokal","year":"2020","journal-title":"and Adolescents Aged 3 to 17 Years Old Through 24 Weeks Posttreatment. Poster at AASLD: The Liver Meeting Digital Experience 2020. Held virtually"},{"issue":"2","key":"10.1016\/j.cld.2022.03.005_bib105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.03.005_bib106","series-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016\u20132021: actions for impact","year":"2021"},{"key":"10.1016\/j.cld.2022.03.005_bib107","series-title":"Global Hepatitis Report 2017","year":"2017"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:21Z","timestamp":1761069561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1089326122000198"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.03.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B and C in Children","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}